These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 603304)
1. Coronary dilatory action of adenosine analogues: a comparative study. Raberger G; Schütz W; Kraupp O Arch Int Pharmacodyn Ther; 1977 Nov; 230(1):140-9. PubMed ID: 603304 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and metabolic actions of an adenosine analogue (2'3'-o-methoxy-ethyliden-adenosine-5'-ethylcarboxamide) in the conscious dog. Raberger G; Schütz W; Kraupp O Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):150-7. PubMed ID: 666456 [TBL] [Abstract][Full Text] [Related]
3. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. Zhao G; Linke A; Xu X; Ochoa M; Belloni F; Belardinelli L; Hintze TH J Pharmacol Exp Ther; 2003 Oct; 307(1):182-9. PubMed ID: 12954805 [TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of adenosine-5'-carboxylic acid-amide in the anaesthetized dog during normal respiration and hypercapnic acidosis. Schütz W; Raberger G Arch Int Pharmacodyn Ther; 1976 Jan; 219(1):140-8. PubMed ID: 1267538 [TBL] [Abstract][Full Text] [Related]
5. The potentiation of the activity of adenosine on coronary blood flow, blood pressure and heart rate by inosine in the dog. Komarek J; Parish GA Arzneimittelforschung; 1975 May; 25(5):737-40. PubMed ID: 1242314 [TBL] [Abstract][Full Text] [Related]
6. Acute dilatory and negative inotropic effects of homocysteine are inhibited by an adenosine blocker. Kennedy RH; Owings R; Joseph J; Melchert RB; Hauer-Jensen M; Boerma M Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):340-4. PubMed ID: 16620298 [TBL] [Abstract][Full Text] [Related]
7. [Progressive increase of the coronary flow above peak reactive hyperemia during prolonged intracoronary infusion of adenosine (author's transl)]. L'Abbate A; Trivella MG; Camici P; Pelosi G; Marzilli M; Ballestra AM; Levantesi D; Taddei L G Ital Cardiol; 1981; 11(4):430-40. PubMed ID: 7286516 [No Abstract] [Full Text] [Related]
8. Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist. Zhao G; Messina E; Xu X; Ochoa M; Sun HL; Leung K; Shryock J; Belardinelli L; Hintze TH J Cardiovasc Pharmacol; 2007 Jun; 49(6):369-75. PubMed ID: 17577101 [TBL] [Abstract][Full Text] [Related]
9. Effects of a 2',3',5'-substituted adenosine derivative on systemic and coronary hemodynamics and on cardiac metabolism in the anesthetized dog. Schütz W; Raberger G; Kraupp O Arzneimittelforschung; 1978; 28(11):2079-82. PubMed ID: 582910 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass. Veres G; Radovits T; Otila G; Hirschberg K; Haider H; Krieger N; Knoll A; Weigang E; Szabolcs Z; Karck M; Szabó G Thorac Cardiovasc Surg; 2010 Mar; 58(2):86-92. PubMed ID: 20333570 [TBL] [Abstract][Full Text] [Related]
11. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats. Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145 [TBL] [Abstract][Full Text] [Related]
12. Comparative coronary vasodilatory effects of nifedipine and niludipine. Ogawa K; Wakamasu Y; Ito T; Suzuki T; Yamazaki N Arzneimittelforschung; 1981; 31(5):770-3. PubMed ID: 7196733 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of myocardial reactive hyperemia and adenosine-induced coronary vasodilation by dilazep, a new adenosine potentiator. Saito D; Kusachi S; Nagashima H; Haraoka S Arzneimittelforschung; 1982; 32(9):1029-32. PubMed ID: 6890820 [TBL] [Abstract][Full Text] [Related]
14. Effects of the water extract of Chrysanthemum indicum Linn. on coronary and systemic hemodynamics in the dog. Kato T; Noguchi K; Sakanashi M; Miyamoto Y; Suekawa M; Aburada M; Hosoya E Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):241-53. PubMed ID: 3718087 [TBL] [Abstract][Full Text] [Related]
15. Effect of adenosine on transmural flow gradients in normal canine myocardium. Leppo JA; Simons M; Hood WB J Cardiovasc Pharmacol; 1984; 6(6):1115-9. PubMed ID: 6084768 [TBL] [Abstract][Full Text] [Related]
16. Differences in vasodilatory response to dipyridamole between patients with angina and normal coronary arteries and patients with successful coronary angioplasty. Finocchiaro ML; Buffon A; Beltrame JF; Lupi A; Conti E; Lanza GA; Cianflone D; Crea F; Maseri A Coron Artery Dis; 1995 Jun; 6(6):479-87. PubMed ID: 7551269 [TBL] [Abstract][Full Text] [Related]
17. Coronary vasoactivity of adenosine in the conscious dog. Olsson RA; Khouri EM; Bedynek JL; McLean J Circ Res; 1979 Oct; 45(4):468-78. PubMed ID: 476869 [TBL] [Abstract][Full Text] [Related]
18. Studies on the coronary dilator actions of some adenosine analogues. Cobbin LB; Einstein R; Maguire MH Br J Pharmacol; 1974 Jan; 50(1):25-33. PubMed ID: 4362949 [TBL] [Abstract][Full Text] [Related]
19. N6-functionalized congeners of adenosine with high potency at A2-adenosine receptors: potential ligands for affinity chromatography. Jacobson KA; Yamada N; Kirk KL; Daly JW; Olsson RA Biochem Biophys Res Commun; 1986 May; 136(3):1097-102. PubMed ID: 3013167 [TBL] [Abstract][Full Text] [Related]